Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Non-Current Deffered Revenue (2024 - 2025)

AC Immune (ACIU) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 43.78% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2025, down 43.78% year-over-year, with the annual reading at $2.9 million for FY2025, 43.78% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $2.9 million at AC Immune, down from $5.2 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $5.2 million in Q4 2024, with the low at $2.9 million in Q4 2025.